Health Care·Life Sciences Tools & Services·$174.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.32 | N/A | +1.30% |
management commentary, guidance changes, and full analysis available with Pro.
| +1.30% |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. They emphasized the importance of customer relationships in driving future growth.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and customer satisfaction.
Thermo Fisher Scientific's strong EPS performance indicates effective cost management and operational efficiency. The stock's 1.22% increase reflects positive investor sentiment following the earnings report. However, the lack of revenue data and guidance may leave some investors cautious about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
HALLIBURTON CO
Jul 22, 2013